Patient’s and Consultant’s Views and Perceptions on Switching from an Originator Biologic to Biosimilar Medication: A Qualitative Study

The aim of this study was to describe the opinions of patients undergoing treatment with originator biologics and medical consultants managing their conditions and identify the barriers and enablers to transitioning from originator biologics to equivalent biosimilars. This study was undertaken prior...

Full description

Bibliographic Details
Main Authors: D. C. Rosembert, M. J. Twigg, D. J. Wright
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/12/2/65